Product Information
LAMOTRIGINE ER 300 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $1.2133 per EA under NDC 00228158003. Its NADAC has been published 529 times since May 11, 2016.
Strength
300 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228158003
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA200672On Market Since
4/1/2016
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 300 MG TABLET has been published 529 times since May 11, 2016, and over the history we have for it it has declined 89.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2133 per EA |
|---|---|
| All-time high | $12.3280 (Nov 16, 2016) |
| All-time low | $0.9867 (Nov 20, 2024) |
| 52-week high | $1.4630 |
| 52-week low | $1.2016 |
| Median price | $4.3055 |
| Average price | $4.6557 |
| Largest weekly change | +59.8% (Jun 19, 2024) |
| Weeks tracked | 529 |
| Tracking since | May 11, 2016 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 300 MG TABLET, manufactured by Actavis Pharma, Inc., is $1.2133 per EA (NDC 00228158003), effective Jun 24, 2026.
How has the price of LAMOTRIGINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 300 MG TABLET has declined 89.6%. It has been tracked across 529 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 300 MG TABLET?
Since May 11, 2016, the NADAC for LAMOTRIGINE ER 300 MG TABLET has ranged from a low of $0.9867 (Nov 20, 2024) to a high of $12.3280 (Nov 16, 2016), with a median of $4.3055 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 300 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as LAMOTRIGINE ER 300 MG TABLET, but none are currently priced below it.
Who manufactures LAMOTRIGINE ER 300 MG TABLET?
LAMOTRIGINE ER 300 MG TABLET (NDC 00228158003) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification